Skip to content
DataLookout
Menu

AMetIPNCT06309680

Accuracy of Metagenomic Blood Sampling to Identify Pathogen in Infective Endocarditis Patients

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Oct 1, 2026 to Oct 1, 2027 Show 5 more changesShow less
    • Eligibility criteria expanded, about 5 words
    • Secondary endpoints: details revised at 2 of 3 entries
    • Study description revised
    • Site details revised
    • Collaborators: details revised at 1 of 2 entries
  2. Notable Primary and study completion dates: Oct 1, 2025 to Oct 1, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  3. Minor Primary and study completion dates: Jul 31, 2025 to Oct 1, 2025v3
  4. Minor Secondary endpoints revised (3)
    • Primary endpoint revised
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Diagnostic accuracy of CMg in blood
Timeframe: 3 years

Secondary (3)

To evaluate the results of Nanopore CMg in identifying the causative organism in patients with BCNIE
1. Optimal timing of blood sampling
3. Metagenomic Techniques

Sites

1 site in 1 country

  • St Bartholomew's Hospital. West SmithfieldLondon, United Kingdom